Novo Holdings A/S

Novo Holdings is a holding and investment company managing the assets of the Novo Nordisk Foundation. Its primary purpose is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns. This is achieved through a diversified investment portfolio encompassing equities, bonds, real estate, infrastructure, private equity, and a significant focus on life science investments. The firm operates with a long-term return perspective, acting as the controlling shareholder of Novo Nordisk A/S and Novonesis A/S. Novo Holdings is a world-leading life sciences investor, investing across all stages of development through its Seed, Venture, Growth, Principal Investments, Planetary Health Investments, and Asia teams. It actively seeks companies that develop innovative drugs, medical devices, and technologies to improve patient care and promote bio-sustainability. The firm's investment strategy also incorporates a commitment to responsible investing, supporting companies that address pressing challenges facing human and planetary health. They manage evergreen capital, which allows for a longer-term investment horizon. The firm emphasizes a values-driven approach, striving for high performance with respect and responsibility. This includes building long-term relationships based on trust and respect, and integrating sustainability into their business practices. They aspire to be catalysts for change, investing in companies that share their commitment to alleviating pressing challenges facing humanity and planetary health. Novo Holdings operates from offices in Copenhagen, London, San Francisco, Boston, Singapore and Shanghai. They invest in clinical diagnostics, industrial biotechnology, biologics supply chain, and healthcare IT. They also focus on promising discoveries that can be translated into applicable biosolutions through planetary health investments.

Biotechnology, Medical Technology, Digital Health, Clinical Diagnostics, Industrial Biotechnology, Biologics Supply Chain, Healthcare IT, Women's Health, Neonatal Care, Pediatric Care, Quantum Technology Ecosystem, Biosolutions

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.